Point72 Asset Management, L.P.

Position in LFCR — Lifecore Biomedical, Inc. \De\

CIK 1603466 STAMFORD, CT

Back to LFCR Full portfolio

Position in LFCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$94,588

-$33,478 QoQ

Shares Held

25,427

+62.4% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

7 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $418,627,713 across 21 Drug Manufacturers - Specialty & Generic names. LFCR ranks #19 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	149,303	$88,533,692
2	LNTH	Lantheus Holdings, Inc.	974,210	$73,893,828
3	SUPN	Supernus Pharmaceuticals, Inc.	1,318,555	$68,156,107
4	HLN	Haleon plc	6,574,038	$65,806,120
5	TEVA	Teva Pharmaceutical Industries Ltd	1,130,507	$34,050,870
6	KNSA	Kiniksa Pharmaceuticals International, plc	640,958	$30,862,127
7	VTRS	Viatris Inc	1,777,181	$24,009,715
8	ADCT	ADC Therapeutics SA	3,382,129	$12,682,983

All Filings in LFCR

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$94,588	25,427	+62.4%	Shares	Defined	2026-05-15
2025-12-31	$128,066	15,656	-88.9%	Shares	Defined	2026-02-17
2022-12-31	$916,570	141,446	-24.0%	Shares	Defined	2023-05-15
2022-09-30	$1,655,353	186,204	-8.6%	Shares	Defined	2022-11-14
2022-06-30	$2,030,889	203,700	-22.1%	Shares	Defined	2022-08-15
2022-03-31	$3,028,818	261,556	+47.8%	Shares	Defined	2022-05-16
2021-12-31	$1,964,910	177,019	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.